methylprednisolone &#160; Turanci (Q417222)

https://www.whocc.no/atc_ddd_index/?code=H02AB04

20 milligram

route of administration ^Turanci

parenteral route of administration ^Turanci

1 reference

https://www.whocc.no/atc_ddd_index/?code=H02AB04

active ingredient in ^Turanci

Medrol ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

202702

retrieved ^Turanci

14 Faburairu 2018

Depo-Medrol ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

22584

retrieved ^Turanci

14 Faburairu 2018

Solu-Medrol ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

203856

retrieved ^Turanci

14 Faburairu 2018

A-MethaPred ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

203857

retrieved ^Turanci

14 Faburairu 2018

World Health Organisation international non-proprietary name ^Turanci

methylprednisolone (Turanci)

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

6alpha-methylprednisolone (Turanci)

retrieved ^Turanci

3 Oktoba 2016

medical condition treated ^Turanci

graft-versus-host disease ^Turanci

3 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

https://www.ncbi.nlm.nih.gov/pubmed/6367162

autoimmune disease ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Sankara

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

hematopoietic system disease ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

inflammation ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

respiratory distress ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

hypersensitivity ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

lupus nephritis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

osteoarthritis susceptibility 1 ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

interstitial lung disease ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

sinusitis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

acute graft versus host disease ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

optic neuritis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

arthritis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

relapsing-remitting multiple sclerosis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Ciwon Nephrotic

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Sclerosis da yawa

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

congenital adrenal hyperplasia ^Turanci

lokacin farawa

23 Oktoba 1957

approved by ^Turanci

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

https://drugs.ncats.io/drug/X4W7ZR7023

http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011153s051lbl.pdf

Rheumatoid amosanin gabbai

lokacin farawa

23 Oktoba 1957

approved by ^Turanci

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

https://drugs.ncats.io/drug/X4W7ZR7023

http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011153s051lbl.pdf

contact dermatitis ^Turanci

lokacin farawa

23 Oktoba 1957

approved by ^Turanci

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

https://drugs.ncats.io/drug/X4W7ZR7023

http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011153s051lbl.pdf

significant drug interaction ^Turanci

nabumetone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

hydrochlorothiazide ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

moxifloxacin ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aspirin ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aspirin ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nabumetone ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

peptic ulcer disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rac-warfarin ^Turanci

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

acenocoumarol ^Turanci

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

moxifloxacin ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rocuronium ^Turanci

muscle weakness ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rocuronium ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atracurium ^Turanci

muscle weakness ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atracurium ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cisatracurium ^Turanci

muscle weakness ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cisatracurium ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

hydrochlorothiazide ^Turanci

heart arrhythmia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

Nuclear receptor subfamily 3 group C member 1 ^Turanci

subject has role ^Turanci

agonist ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

7088

retrieved ^Turanci

17 Agusta 2016

pregnancy category ^Turanci

Australian pregnancy category A ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

manufacturer ^Turanci

Pfizer ^Turanci

1 reference

https://www.pfizer.com/products/product-list

subject has role ^Turanci

5-lipoxygenase inhibitor ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

selective glucocorticoid receptor agonist ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

neuroprotective agent ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

anti-inflammatory agent ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

antiemetic ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

glucocorticoid ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

essential medicine ^Turanci

0 references

stylized name ^Turanci

methylPREDNISolone

has characteristic ^Turanci

Tall Man lettering ^Turanci

issued by ^Turanci

subject named as ^Turanci

Methylprednisolone

1 reference

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

retrieved ^Turanci

2 Satumba 2022

has part(s) ^Turanci

carbon ^Turanci

0 references

Commons category ^Turanci

Methylprednisolone

0 references

Identifiers

InChI ^Turanci

InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChIKey ^Turanci

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

83-43-2

2 references

stated in ^Turanci

UNII ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChIKey ^Turanci

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

9 Afirilu 2021

https://commonchemistry.cas.org/detail?cas_rn=83-43-2

ChemSpider ID ^Turanci

6485

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

Methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

PubChem CID ^Turanci

6741

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChIKey ^Turanci

Reaxys registry number ^Turanci

2340300

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

6alpha-methylprednisolone (Turanci)

retrieved ^Turanci

3 Oktoba 2016

ChEBI ID ^Turanci

6888

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

METHYLPREDNISOLONE (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1

International Chemical Identifier ^Turanci

InChI ^Turanci

ChEMBL ID ^Turanci

CHEMBL650

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

METHYLPREDNISOLONE (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

SureChEMBL ID ^Turanci

SCHEMBL5084

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

MSBNK-Athens_Univ-AU107601

UniChem compound ID ^Turanci

292368

1 reference

stated in ^Turanci

UniChem ^Turanci

MassBank accession ID ^Turanci

0 references

MSBNK-Athens_Univ-AU107602

0 references

MSBNK-Athens_Univ-AU107603

0 references

MSBNK-Athens_Univ-AU107604

0 references

MSBNK-Athens_Univ-AU107605

0 references

MSBNK-Athens_Univ-AU107607

0 references

MSBNK-Athens_Univ-AU107608

0 references

MSBNK-Athens_Univ-AU107609

0 references

MSBNK-Athens_Univ-AU107610

0 references

MSBNK-Athens_Univ-AU107611

0 references

MSBNK-Athens_Univ-AU107630

0 references

MSBNK-Athens_Univ-AU107631

0 references

MSBNK-Athens_Univ-AU107632

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

SPLASH ^Turanci

splash10-0k9i-0696000000-003c4527b983cf71aefd

0 references

splash10-01p9-0980000000-e5097669b38e84057a0f

0 references

splash10-01p9-0960000000-ef914702163187cc80af

0 references

splash10-06y9-0940000000-54b01b6c04c68be3f1b3

0 references

splash10-0a4i-0009000000-3fe2869617af3697e2ed

0 references

splash10-0a4i-0009000000-8ad4f169606968256614

0 references

splash10-0f79-0895000000-29d1cbf49bb2b32c5a98

0 references

splash10-01p9-0940000000-baa402ac94c228229ea2

0 references

splash10-01p9-0910000000-5cf9fb219d798a9316f4

0 references

splash10-0a4r-0910000000-a2d2af7f573229dc3147

0 references

splash10-0006-2900000000-a01d5bfe926dc48e6e4c

0 references

splash10-0a4i-0019000000-11519ee9583104c00505

0 references

splash10-0gw0-0974000000-af5d4ebce055ce6efb23

0 references

splash10-01p9-0960000000-22e2342fcec2bf1cd833

0 references

splash10-01p9-0920000000-63759535c53af1efb13f

0 references

splash10-0c09-1900000000-a48c07db31cf27cf0381

0 references

splash10-05tp-2900000000-b802f5e17b69cd6c707f

0 references

splash10-0a4i-0009000000-0e0cc8bfc7721357c5cf

0 references

splash10-0bti-0896000000-86854a3fa2cb3c3bde0b

0 references

splash10-0a4r-0796000000-b0070da713077c3f7975

0 references

splash10-01p9-3950000000-b938f656c358e1e42bb5

0 references

splash10-0fe0-0149000000-e2764c4911c33cde9fad

0 references

HSDB ID ^Turanci

3127

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

3127

28 Oktoba 2019

laƙabi

METHYLPREDNISOLONE (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID7023300

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

InChIKey ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID903300

0 references

NSC number ^Turanci

19987

0 references

757115

0 references

EC number ^Turanci

201-476-4

1 reference

stated in ^Turanci

UNII ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

ECHA Substance Infocard ID ^Turanci

100.001.343

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.001.343

retrieved ^Turanci

27 Disamba 2018

laƙabi

Methylprednisolone (Turanci)

quotation ^Turanci

CAS no.: 83-43-2 (Turanci)

AICS Chemical ID (BEING DELETED) ^Turanci

1228

0 references

Lambar ATC

D10AA02

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Methylprednisolone (Turanci)

17 Nuwamba 2015

H02AB04

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Methylprednisolone (Turanci)

17 Nuwamba 2015

D07AA01

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Methylprednisolone (Turanci)

17 Nuwamba 2015

National Drug Code ^Turanci

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Guide to Pharmacology Ligand ID ^Turanci

7088

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

MeSH descriptor ID ^Turanci

D04.210.500.745.432.769.795.539

subject named as ^Turanci

Methylprednisolone

0 references

MeSH concept ID ^Turanci

M0013662

0 references

Lambar itace MeSH

0 references

RxNorm ID ^Turanci

6902

1 reference

stated in ^Turanci

UNII ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

DrugBank ID ^Turanci

DB00959

1 reference

InChIKey ^Turanci

Human Metabolome Database ID ^Turanci

HMDB0015094

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

UNII ^Turanci

X4W7ZR7023

2 references

stated in ^Turanci

UNII ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChIKey ^Turanci

MedlinePlus drug identifier ^Turanci

a682795

route of administration ^Turanci

oral administration ^Turanci

0 references

a601157

route of administration ^Turanci

intramuscular injection ^Turanci

intravenous injection ^Turanci

0 references

PatientsLikeMe treatment ID ^Turanci

methylprednisolone

0 references

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

UNII ^Turanci

methylprednisolone (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

Probes And Drugs ID ^Turanci

PD003097

0 references

DrugCentral ID ^Turanci

1768

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

D00407

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

6alpha-methylprednisolone (Turanci)

retrieved ^Turanci

3 Oktoba 2016

LIPID MAPS ID ^Turanci

LMST02030178

1 reference

stated in ^Turanci

LIPID MAPS ^Turanci

http://www.lipidmaps.org/rest/compound/lm_id/LM/all/download

retrieved ^Turanci

30 Yuni 2018

DeCS ID ^Turanci

22562

0 references

electronic Essential Medicines List medicine ID ^Turanci

114

0 references

Freebase ID ^Turanci

/m/05zwj8

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

28 Oktoba 2013

Microsoft Academic ID ^Turanci

2780372218

0 references

OpenAlex ID ^Turanci

C2780372218

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Quora topic ID ^Turanci

Methylprednisolone

1 reference

stated in ^Turanci

Quora ^Turanci

UMLS CUI ^Turanci

C0025815

1 reference

stated in ^Turanci